T9175 |
Casein Kinase inhibitor A51
|
2079068-74-7
|
98.42%
|
|
Casein Kinase inhibitor A51 is an orally active casein kinase 1α (CK1α) inhibitor with anticancer activity that induces apoptosis in leukemia cells, and may be u...
|
T78622 |
Ac-VDVAD-CHO
|
194022-51-0
|
98%
|
|
Ac-VDVAD-CHO is an inhibitor of caspase-2 and caspase-3 (IC50: 46 nM for caspase-2 and 15 nM for caspase-3) [1].
|
T79127 |
Casein kinase 1δ-IN-4
|
851168-98-4
|
98%
|
|
"Casein kinase 1δ-IN-4 (compound 567) is a potent inhibitor of casein kinase 1δ with potential application in Alzheimer's disease research [1]."
|
T79145 |
CK1-IN-2
|
1383376-92-8
|
98%
|
|
CK1-IN-2 (compound Nr.4) is a potent inhibitor of CK1, exhibiting IC50 values of 123 nM for CK1a, 19.8 nM for CK1d, 26.8 nM for CK1e, and 74.3 nM for p38a [1].
|
T79154 |
Casein kinase 1δ-IN-5
|
1579991-10-8
|
98%
|
|
Casein kinase 1δ-IN-5 is a potent and selective CK-1δ inhibitor, exhibiting an IC50 of 47 nM, and demonstrates neuroprotective and anti-inflammatory effects in v...
|
T79697 |
Casein kinase 1δ-IN-10
|
332074-85-8
|
98%
|
|
Casein kinase 1δ-IN-10 is an inhibitor of casein kinase 1δ (CK1δ) referenced in WO2012080729A2 as compound 685 [1].
|
T79908 |
ON 108600
|
1585246-23-6
|
98%
|
|
ON 108600 is a chemical inhibitor targeting CK2 (Casein Kinase 2), TNIK, and DYRK1, demonstrating IC50 values of 0.016 μM and 0.007 μM for DYRK1A and DYRK1B, 0.0...
|
T80076 |
Ac-ESMD-CHO
|
191338-87-1
|
98%
|
|
Ac-ESMD-CHO functions as an inhibitor of both caspase-3 and caspase-7, specifically obstructing the proteolytic cleavage of the caspase-3 precursor peptide (CPP3...
|
T16507 |
PF-5006739
|
1293395-67-1
|
98%
|
|
PF-5006739 is an effective and selective inhibitor of CK1δ/ε (IC50s: 3.9 nM and 17.0 nM, respectively). PF-5006739 is a potential therapeutic agent for a range o...
|
T10829 |
CKI-7 free base
|
120615-25-0
|
98%
|
|
CKI-7 free base is a potent and ATP-competitive inhibitor of casein kinase 1 (CK1; IC50: 6 μM; Ki: 8.5 μM) and a selective Cdc7 kinase inhibitor. CKI-7 free base...
|
T8305 |
Ellagic acid (hydrate)
|
314041-08-2
|
98%
|
|
Ellagic acid (hydrate) is a natural antioxidant and acts as a potent and ATP-competitive CK2 inhibitor (IC50:40 nM, Ki: 20 nM).
|
T71627 |
CX-5011
|
1009821-06-0
|
98%
|
|
CX-5011, a CK2 inhibitor, induces Rac1 activation and promotes apoptosis, effectively causing cancer cell death [1] [2].
|
T2440 |
IC261
|
186611-52-9
|
99.86%
|
|
IC261 (SU-5607) is a novel inhibitor of CK1, triggers the mitotic checkpoint control. The IC50 of IC261 for CK1 was 16 μM and for Cdk5 is 4.5 mM.
|
T6735 |
XL413 hydrochloride
|
2062200-97-7
|
99.82%
|
|
XL413 hydrochloride (BMS-863233 Hydrochloride) is a potent, selective and ATP competitive inhibitor of Cdc7, with an IC 50 of 3.4 nM. XL413 hydrochloride also ex...
|
T2449 |
D4476
|
301836-43-1
|
99.8%
|
|
D4476 (Casein Kinase I Inhibitor) is an effective, selective, and cell-permeant CK1 (casein kinase 1) inhibitor( IC50=300 nM in a cell-free assay).
|
T14069 |
A-3 hydrochloride
|
78957-85-4
|
99.79%
|
|
A-3 hydrochloride is a potent, cell-permeable, reversible, ATP-competitive non-selective antagonist of various kinases. A-3 hydrochloride also inhibits PKC and c...
|
T2008 |
LY294002
|
154447-36-6
|
99.76%
|
|
LY294002 (SF 1101) is a broad-spectrum inhibitor of PI3K, inhibiting PI3Kα, PI3Kδ, and PI3Kβ (IC50=0.5/0.57/0.97 μM). LY294002 is also an inhibitor of DNA-PK (IC...
|
T0465 |
Ellagic acid
|
476-66-4
|
99.76%
|
|
Ellagic acid (Gallogen) is a fused four ring compound isolated from the kino of Eucalyptus maculata Hook and E. Hemipholia F. Muell. Activates Factor XII of the ...
|
T9356 |
(E/Z)-GO289
|
694522-87-7
|
99.68%
|
|
(E/Z)-GO289, which strongly lengthened circadian period, is a potent and selective inhibitor of CK2. (E/Z)-GO289 exhibited cell type-dependent inhibition of canc...
|
T2048 |
LY-364947
|
396129-53-6
|
99.65%
|
|
LY-364947 (HTS466284) is a potent ATP-competitive inhibitor of TGFβR-I.
|